NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it has awarded $5.5 million in new funding to support the development of blood-based tests for Alzheimer's disease and related dementias.
NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it has awarded $5.5 million in new funding to support the development of blood-based tests for Alzheimer's disease and related dementias.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.